Skip to main content
DNA Labs India

MYH2 Gene Inclusion body myopathy NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

MYH2 Gene Inclusion body myopathy NGS Genetic Test

Short Name: MYH2 IBM NGS Genetic Test

Also known as: MYH2-related inclusion body myopathy genetic test, Hereditary inclusion body myopathy NGS test, MYH2 gene mutation analysis

MYH2 Gene Inclusion body myopathy NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in 3 to 4 weeks after the sample reaches the laboratory.. Free home collection in 300+ cities across India.

NGS Genetic TestAdults🏠 Home Collection

🩺 Medically Reviewed By

Overview

The test is used to identify disease-causing variants in the MYH2 gene and to support the clinical diagnosis of inclusion body myopathy in patients with compatible signs and symptoms.

Test Code
4152
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
3 to 4 weeks after the sample reaches the laboratory.
Fasting Required
No
Method
Next Generation Sequencing (NGS)
Step 1

Sample Collection

A genetic counselling session is recommended to draw a pedigree chart of affected family members and to discuss the benefits, risks, and limitations of NGS testing.

Method: Venipuncture or FTA card blood spot

Step 2

Laboratory Analysis

A standard venipuncture or FTA card blood spot sample is collected. No sedation or anesthesia is required.

Step 3

Report Delivery

No specific post-collection precautions are needed. The sample is sent to the laboratory for DNA extraction and next-generation sequencing.

Timeline: 3 to 4 weeks after the sample reaches the laboratory.

Patient Instructions

1
Before the Test:A genetic counselling session is recommended to review family history, draw a pedigree chart, and obtain informed consent before testing.
2
During the Test:A small blood sample or FTA card spot is collected. The procedure is quick and generally painless.
3
After the Test:The sample is processed in the laboratory. Reports are shared online through the patient portal or via email/WhatsApp.

About This Test

Who Should Get This Test

The test is used to identify disease-causing variants in the MYH2 gene and to support the clinical diagnosis of inclusion body myopathy in patients with compatible signs and symptoms.

How to Prepare

  • No fasting is required
  • EDTA whole blood: 2-3 mL; extracted DNA: 1-2 µg; FTA card: one blood spot
  • Complete the requisition form with clinical history and family pedigree
  • Sample should be clearly labelled with patient name, date of birth, and collection date
  • Whole blood should be stored at 2-8°C until shipment; FTA card must be dried at room temperature

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic counselling is essential in hereditary myopathies. Testing should be performed after a detailed family history and with informed consent, and result interpretation should include familial segregation when a variant of uncertain significance is found."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 mL whole blood / 1-2 µg extracted DNA / 1 FTA card spot
ContainerEDTA vacutainer / FTA card / DNA sample vial
Collection MethodVenipuncture or FTA card blood spot

Sample Stability

Whole blood in EDTA: up to 48 hours at 2-8°C
FTA card: up to 7 days at ambient room temperature
Extracted DNA: stable at -20°C for several months
Sample Rejection Criteria:
  • Clotted or haemolysed blood sample
  • Sample without proper labeling
  • Insufficient sample quantity or DNA concentration
  • Non-viable or wet FTA card
  • Missing clinical history or family pedigree

Understanding Your Results

MYH2 gene inclusion body myopathy is caused by pathogenic variants in the MYH2 gene. This NGS test evaluates the coding regions and splice sites of the MYH2 gene. Results are interpreted in the context of clinical history, family pedigree, and muscle biopsy findings.
📊

No pathogenic variant detected

No disease-causing MYH2 variant was found; clinical diagnosis should be re-evaluated and other genes considered.

📊

Pathogenic variant detected

Identified variant is known to cause disease; genetic counselling and cascade testing for at-risk relatives are recommended.

📊

Variant of uncertain significance (VUS)

A variant was found but its effect is unknown; additional testing in family members may help determine significance.

⚠️ When to Consult a Doctor:

Consult a neurologist or clinical geneticist if you or a family member experience progressive muscle weakness, difficulty in climbing stairs or rising from a chair, swallowing difficulties, or speech problems, particularly if there is a family history of inclusion body myopathy.

Limitations

  • Targeted NGS does not detect large gene rearrangements, trinucleotide repeats, or epigenetic changes
  • Variant of uncertain significance may require family segregation studies
  • Negative result does not exclude other genetic causes of inclusion body myopathy
  • Results should be interpreted by a clinical geneticist in the context of clinical findings

Risks & Considerations

  • Minor pain, bruising, or bleeding at the venipuncture site
  • Psychological or emotional impact of a genetic result
  • Possible identification of a variant of uncertain significance

Interfering Factors

  • Variants in non-coding regulatory regions may not be captured by targeted NGS
  • Regions with extremely high GC content may reduce sequencing depth
  • Contamination during sample collection or processing can affect results
  • Incorrect sample labeling or incomplete clinical history may cause misinterpretation

Frequently Asked Questions

What is the MYH2 gene inclusion body myopathy NGS genetic test?
It is a targeted next-generation sequencing test that reads MYH2 gene coding regions and nearby splice sites to detect variants that can cause inclusion body myopathy. DNA Labs India includes clinical interpretation as well as raw data (FASTQ, VCF) files.
Which sample is needed for this test?
Blood, extracted DNA, or one drop of blood on an FTA card can be used. EDTA blood or an FTA card is accepted for home collection.
Is fasting required before the test?
No, fasting is not required.
How much does the test cost at DNA Labs India?
The test is available at the special price of INR 20,000 in India. Online bookings include free home sample collection in many cities.
What is the turnaround time for the report?
Reports are generally delivered in 3 to 4 weeks.
What conditions can be detected by this test?
This test detects pathogenic variants in the MYH2 gene associated with hereditary inclusion body myopathy, a progressive muscle disorder causing weakness and wasting, swallowing and speech difficulties.
Can MYH2-related myopathy be diagnosed by clinical examination alone?
Clinical examination, elevated creatine kinase, electromyography, and muscle biopsy are helpful, but genetic testing is required to confirm a MYH2 gene diagnosis. NGS provides a broad analysis of the gene.
What does a negative result mean?
A negative result means no pathogenic MYH2 variant was identified. It does not completely exclude inclusion body myopathy due to other genes or non-genetic causes; further testing may still be advised.
What does a positive result mean?
A positive result identifies a pathogenic or likely pathogenic variant in MYH2. This supports the diagnosis and helps guide family planning and counseling.
What is a variant of uncertain significance (VUS)?
A VUS is a genetic change whose effect on protein function is not yet clearly known. It may require familial segregation studies or additional clinical information to interpret.
Will DNA Labs India provide raw data files?
Yes, DNA Labs India provides raw data, FASTQ, and VCF files along with the conclusive clinical report for transparency and future analysis.
How can I book the test?
You can book online through the DNA Labs India website; free home sample collection is offered in major cities including Delhi, Mumbai, Bangalore, Hyderabad, Chennai, Kolkata, Pune, and Ahmedabad.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.